Results for tag: "Hypereosinophilic Drug"

The Hypereosinophilic Drug market is a subset of Immune Disorders Drugs, which are used to treat a variety of conditions related to the immune system. Hypereosinophilic Drugs are used to treat a rare group of diseases characterized by an abnormally high number of eosinophils in the blood. These drugs are used to reduce the number of eosinophils and to reduce inflammation and tissue damage caused by the eosinophils. Common side effects of these drugs include nausea, vomiting, diarrhea, and headache. Some of the companies in the Hypereosinophilic Drug market include Novartis, GlaxoSmithKline, Sanofi, Pfizer, and Merck. These companies are involved in the research, development, and marketing of Hypereosinophilic Drugs. Additionally, there are several smaller companies that are involved in the development and marketing of these drugs. Show Less Read more